• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间皮素变体1作为一种诊断标志物从肿瘤细胞中释放出来。

Mesothelin variant 1 is released from tumor cells as a diagnostic marker.

作者信息

Hellstrom Ingegerd, Raycraft John, Kanan Sandra, Sardesai Niranjan Y, Verch Thorsten, Yang Yi, Hellstrom Karl Erik

机构信息

Department of Pathology, Harborview Medical Center, University of Washington, 325 9th Avenue, Box 35 99 39, Seattle, WA 98104, USA.

出版信息

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1014-20. doi: 10.1158/1055-9965.EPI-05-0334.

DOI:10.1158/1055-9965.EPI-05-0334
PMID:16702385
Abstract

The mesothelin family comprises (at least) three variants and includes the precursor for megakaryocyte potentiating factor (MPF). Assaying soluble mesothelin-related protein (SMRP) molecules in serum and other body fluids from patients with certain cancers can provide diagnostically useful information. We have constructed fusion proteins of mesothelin variants 1, 2, and 3, made monoclonal antibodies, and investigated the binding specificity of these and three previously generated monoclonal antibodies to each of the three mesothelin variants. According to flow cytometry, the molecule that is most frequently expressed at the surface of cells from ovarian carcinomas and certain other tumors is mesothelin variant 1. Similarly, SMRP released into ascites from a patient with ovarian carcinoma was shown to have a molecular weight of approximately 40 kDa and, according to sequencing, to be variant 1. A published sandwich ELISA was shown to detect variants 1 and 3 and to be much more sensitive than a newly constructed ELISA, which detects only variant 3, the former being positive in 28 of 41 (68%) sera from patients with ovarian cancer as compared with 6 of 41 sera (15%). A standard curve was constructed to measure SMRP with a limit of detection of 200 pg/mL to facilitate future quantitative studies.

摘要

间皮素家族(至少)包含三种变体,其中包括巨核细胞增强因子(MPF)的前体。检测某些癌症患者血清和其他体液中的可溶性间皮素相关蛋白(SMRP)分子可提供诊断有用信息。我们构建了间皮素变体1、2和3的融合蛋白,制备了单克隆抗体,并研究了这些抗体以及之前产生的三种单克隆抗体与三种间皮素变体各自的结合特异性。根据流式细胞术,卵巢癌和某些其他肿瘤细胞表面最常表达的分子是间皮素变体1。同样,从一名卵巢癌患者腹水中释放的SMRP显示分子量约为40 kDa,经测序为变体1。已发表的夹心ELISA检测变体1和3,且比新构建的仅检测变体3的ELISA更灵敏,前者在41份卵巢癌患者血清中的28份(68%)呈阳性,而后者在41份血清中的6份(15%)呈阳性。构建了标准曲线以测量SMRP,检测限为200 pg/mL,以便于未来的定量研究。

相似文献

1
Mesothelin variant 1 is released from tumor cells as a diagnostic marker.间皮素变体1作为一种诊断标志物从肿瘤细胞中释放出来。
Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1014-20. doi: 10.1158/1055-9965.EPI-05-0334.
2
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma.在卵巢癌患者的血清中可检测到间皮素/巨核细胞增强因子家族的可溶性成员。
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11531-6. doi: 10.1073/pnas.96.20.11531.
3
Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.人胰腺导管癌中N-ERC/间皮素的分泌及C-ERC/间皮素的表达
Oncol Rep. 2008 Dec;20(6):1375-80.
4
Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.血清间皮素的检测与定量,间皮素是一种用于间皮瘤和卵巢癌患者的肿瘤标志物。
Clin Cancer Res. 2006 Jan 15;12(2):447-53. doi: 10.1158/1078-0432.CCR-05-1477.
5
MESOMARK kit detects C-ERC/mesothelin, but not SMRP with C-terminus.MESOMARK检测试剂盒可检测C-ERC/间皮素,但不能检测带有C端的SMRP。
Biochem Biophys Res Commun. 2008 May 9;369(3):915-8. doi: 10.1016/j.bbrc.2008.02.114. Epub 2008 Mar 5.
6
Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer.可溶性间皮素相关蛋白在恶性胸膜间皮瘤患者中的诊断和预后价值:与良性石棉肺和肺癌的比较
J Thorac Oncol. 2008 Nov;3(11):1317-24. doi: 10.1097/JTO.0b013e318187491c.
7
Novel ELISA system for detection of N-ERC/mesothelin in the sera of mesothelioma patients.用于检测间皮瘤患者血清中N-ERC/间皮素的新型酶联免疫吸附测定系统。
Cancer Sci. 2006 Sep;97(9):928-32. doi: 10.1111/j.1349-7006.2006.00246.x. Epub 2006 Jun 7.
8
Characterization of human mesothelin transcripts in ovarian and pancreatic cancer.卵巢癌和胰腺癌中人间皮素转录本的特征分析
BMC Cancer. 2004 May 12;4:19. doi: 10.1186/1471-2407-4-19.
9
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.尿间皮素对早期卵巢癌的诊断敏感性高于血清间皮素、尿游离人绒毛膜促性腺激素β亚基和尿人绒毛膜促性腺激素β核心片段。
Gynecol Oncol. 2007 Sep;106(3):490-7. doi: 10.1016/j.ygyno.2007.04.022. Epub 2007 May 25.
10
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin.巨核细胞增强因子作为恶性胸膜间皮瘤的肿瘤标志物:与间皮素相比的评估
Lung Cancer. 2008 Oct;62(1):45-54. doi: 10.1016/j.lungcan.2008.02.012. Epub 2008 Apr 3.

引用本文的文献

1
Characterization of mesothelin gene expression in dogs and overexpression in canine mesotheliomas.犬中皮素基因表达的特征及在犬间皮瘤中的过表达
Front Vet Sci. 2024 Sep 9;11:1436621. doi: 10.3389/fvets.2024.1436621. eCollection 2024.
2
Generation of a Novel Mesothelin-Targeted Oncolytic Virus and Implemented Strategies for Manufacturing.新型间皮素靶向溶瘤病毒的构建及其生产策略。
Int J Mol Sci. 2021 Jan 6;22(2):477. doi: 10.3390/ijms22020477.
3
Multiple proteases are involved in mesothelin shedding by cancer cells.多种蛋白酶参与癌细胞表面间皮素的脱落。
Commun Biol. 2020 Dec 1;3(1):728. doi: 10.1038/s42003-020-01464-5.
4
Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural Mesothelioma.用于恶性胸膜间皮瘤的基于血液的靶向蛋白质组学标志物的验证。
Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):1973-1982. doi: 10.1158/1055-9965.EPI-20-0543. Epub 2020 Jul 30.
5
Clinical Response of Live-Attenuated, Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma.表达间皮素的活减(CRS-207)联合化疗治疗恶性胸膜间皮瘤患者的临床反应。
Clin Cancer Res. 2019 Oct 1;25(19):5787-5798. doi: 10.1158/1078-0432.CCR-19-0070. Epub 2019 Jul 1.
6
The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment.间皮素在卵巢癌肿瘤微环境中的作用
Cancers (Basel). 2018 Aug 21;10(9):277. doi: 10.3390/cancers10090277.
7
Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.间皮素在胸腺癌中的表达及其潜在治疗意义。
Lung Cancer. 2016 Nov;101:104-110. doi: 10.1016/j.lungcan.2016.09.015. Epub 2016 Sep 28.
8
Establishment of anti-mesothelioma monoclonal antibodies.抗间皮瘤单克隆抗体的建立。
BMC Res Notes. 2016 Jun 24;9:324. doi: 10.1186/s13104-016-2128-x.
9
Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.几种生物标志物对恶性胸膜间皮瘤患者的预后价值。
Tumour Biol. 2015 Sep;36(10):7375-84. doi: 10.1007/s13277-015-4063-1. Epub 2015 Sep 11.
10
Discovery of new biomarkers for malignant mesothelioma.恶性间皮瘤新生物标志物的发现
Curr Pulmonol Rep. 2015;4(1):15-21. doi: 10.1007/s13665-015-0106-8.